Role of birthweight in the etiology of breast cancer

International Journal of Cancer

Volumn 119, Issue 9, 2006, Pages 2007-2025

  Michels, Karin B ^a,b   Xue, Fei ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Birthweight; Breast cancer; Epidemiology; Epigenetics; Stem cells

Indexed keywords

GROWTH FACTOR; SOMATOMEDIN B;

BIRTH WEIGHT; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION REGULATION; GENOME IMPRINTING; HIGH BIRTH WEIGHT; HUMAN; MAMMARY GLAND; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PREMENOPAUSE; PRENATAL GROWTH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; STEM CELL;

BIRTH WEIGHT; BODY SIZE; BREAST NEOPLASMS; FEMALE; FETAL DEVELOPMENT; GESTATIONAL AGE; HUMANS; PREGNANCY; RISK ASSESSMENT;

EID: 33748872097     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22004     Document Type: Short Survey

References (133)

1. Trichopoulos D. Hypothesis: does breast cancer originate in utero? Lancet 1990;335:939-40.
2. Trichopoulos D. Is breast cancer initiated in utero? Epidemiology 1990;1:95-6.
3. Land CE. Studies of cancer and radiation dose among atomic bomb survivors: the example of breast cancer. JAMA 1995;274:402-7.
4. Hildreth NG, Shore RE, Dvoretsky PM, The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 1989;321:1281-4.
5. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet 1992;340:1015-8.
6. Rothman KJ, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Trichopoulos D, Yuasa S. Maternal age and birth rank of women with breast cancer. J Natl Cancer Inst 1980;65:719-22.
7. Le Marchand L, Kolonel LN, Myers BC, Mi MP. Birth characteristics of premenopausal women with breast cancer. Br J Cancer 1988;57:437-9.
8. Janerich DT, Hayden CL, Thompson WD, Selenskas SL, Mettlin C. Epidemiologic evidence of perinatal influence in the etiology of adult cancers. J Clin Epidemiol 1989;42:151-7.
9. Thompson WD, Janerich DT. Maternal age at birth and risk of breast cancer in daughters, Epidemiology 1990;1:101-6.
10. Zhang Y, Cupples LA, Rosenberg L, Colton T, Kreger BE. Parental ages at birth in relation to a daughter's risk of breast cancer among female participants in the Framingham Study (United States). Cancer Causes Control 1995;6:23-9.
11. Innes K, Byers T, Schymura M. Birth characteristics and subsequent risk for breast cancer in very young women. Am J Epidemiol 2000;152:1121-8.
12. Hodgson ME, Newman B, Millikan RC. Birthweight, parental age, birth order and breast cancer risk in African-American and white women: a population-based case-control study. Breast Cancer Res 2004;6:R656-R667.
13. Panagiotopoulou K, Katsouyanni K, Petridou E, Garas Y, Tzonou A, Trichopoulos D. Maternal age, parity and pregnancy estrogens. Cancer Causes Control 1990;1:119-124.
14. Bennett A, Wilson DM, Liu F, Nagashima R, Rosenfeld RG, Hintz RL. Levels of insulin-like growth factors I and II in human cord blood. J Clin Endocrinol Metab 1983;57:609-12.
15. Reece EA, Wiznitzer A, Le E, Homko CJ, Behrman H, Spencer EM. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins and receptors. Obstet Gynecol 1994;84:88-95.
16. Baldwin S, Chung M, Chard T, Wang HS. Insulin-like growth factor-binding-protein-1, glucose tolerance and fetal growth in human pregnancy. J Endocrinol 1993;136:319-25.
17. Hills FA, English J, Chard T. Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol 1996;148:303-9.
18. Petridou E, Panagiotopoulou K, Katsouyanni K, Spanos E, Trichopoulos D, Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology 1990;1:247-50.
19. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 2000;21:40-54.
20. Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI. Growth patterns and the risk of breast cancer in women. N Engl J Med 2004;351:1619-26.
21. Kaijser M, Lichtenstein P, Granath F, Erlandsson G, Cnattingius S, Ekbom A. In utero exposures and breast cancer: a study of opposite-sexed twins. J Natl Cancer Inst 2001;93:60-2.
22. Ahlgren M, Sorensen T, Wohlfahrt J, Haflidadottir A, Holst C, Melbye M. Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer 2003;107:997-1000.
23. McCormack VA, dos Santos Silva I, De Stavola BL, Mohsen R, Leon DA, Lithell HO. Fetal growth and subsequent risk of breast cancer: results from long term follow up of Swedish cohort. BMJ 2003;326:248.
24. DeStavola BL, Hardy R, Kuh D, Silva IS, Wadsworth M, Swerdlow AJ. Birthweight, childhood growth and risk of breast cancer in a British cohort. Br J Cancer 2000;83:964-8.
25. McCormack VA, dos Santos Silva I, Koupil I, Leon DA, Lithell HO. Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women. Int J Cancer 2005;115:611-7.
26. dos Santos Silva I, De Stavola BL, Hardy RJ, Kuh DJ, McCormack VA, Wadsworth ME. Is the association of birth weight with premenopausal breast cancer risk mediated through childhood growth? Br J Cancer 2004;91:519-24.
27. Review Manager (RevMan) [Computer program]. Version 4.2 for Windows. Oxford, England: The Cochrane Collaboration, 2003.
28. RevMan Analyses [Computer program]. Version 1.0 for Windows. In: Review Manager (RevMan) 4.2. Oxford, England: The Cochrane Collaboration, 2003.
29. Sanderson M, Williams MA, Malone KE, Stanford JL, Emanuel I, White E, Daling JR. Perinatal factors and risk of breast cancer. Epidemiology 1996;7:34-7.
30. Michels KB, Trichopoulos D, Robins JM, Rosner BA, Manson JE, Hunter DJ, Colditz GA, Hankinson SE, Speizer FE, Willett WC. Birthweight as a risk factor for breast cancer. Lancet 1996;348:1542-6.
31. Ekbom A, Hsieh CC, Lipworth L, Adami HQ, Trichopoulos D. Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst 1997;89:71-6.
32. Sanderson M, Williams MA, Daling JR, Holt VL, Malone KE, Self SG, Moore DE. Maternal factors and breast cancer risk among young women. Paediatr Perinat Epidemiol 1998;12:397-407.
33. Mogren I, Damber L, Tavelin B, Hogberg U. Characteristics of pregnancy and birth and malignancy in the offspring(Sweden). Cancer Causes Control 1999;10:85-94.
34. Hubinette A, Lichtenstein P, Ekbom A, Cnattingius S. Birth characteristics and breast cancer risk: a study among like-sexed twins. Int J Cancer 2001;91:248-51.
35. Andersson SW, Bengtsson C, Hallberg L, Lapidus L, Niklasson A, Wallgren A, Hulthen L. Cancer risk in Swedish women: the relation to size at birth. Br J Cancer 2001;84:1193-8.
36. Hilakivi-Clarke L, Forsen T, Eriksson JG, Luoto R, Tuomilehto J, Osmond C, Barker DJ. Tallness and overweight during childhood have opposing effects on breast cancer risk. Br J Cancer 2001;85:1680-4.
37. Vatten LJ, Maehle BO, Lund Nilsen TI, Tretli S, Hsieh CC, Trichopoulos D, Stuver SO. Birth weight as a predictor of breast cancer: a case-control study in Norway. Br J Cancer 2002;86:89-91.
38. Sanderson M, Shu XO, Jin F, Dai Q, Ruan Z, Gao YT, Zheng W. Weight at birth and adolescence and premenopausal breast cancer risk in a low-risk population. Br J Cancer 2002;86:84-8.
39. Titus-Ernstoff L, Egan KM, Newcomb PA, Ding J, Trentham-Dietz A, Greenberg ER, Baron JA, Trichopoulos D, Willett WC. Early life factors in relation to breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:207-10.
40. Mellemkjaer L, Olsen ML, Sorensen HT, Thulstrup AM, Olsen J, Olsen JH. Birth weight and risk of early-onset breast cancer (Denmark). Cancer Causes Control 2003;14:61-4.
41. Kaijser M, Akre O, Cnattingius S, Ekbom A. Preterm birth, birth weight, and subsequent risk of female breast cancer. Br J Cancer 2003;89:1664-6.
42. Lahmann PH, Gullberg B, Olsson H, Boeing H, Berglund G, Lissner L. Birth weight is associated with postmenopausal breast cancer risk in Swedish women. Br J Cancer 2004;91:1666-8.
43. Vatten LJ, Nilsen TI, Tretli S, Trichopoulos D, Romundstad PR. Size at birth and risk of breast cancer: prospective population-based study. Int J Cancer 2005;114:461-4.
44. Sedin G, Bergquist C, Lindgren PG. Ovarian hyperstimulation in preterm infants. Pediatr Res 1985;19:548-52.
45. Ekbom A, Erlandsson G, Hsieh C, Trichopoulos D, Adami HO, Cnattingius S. Risk of breast cancer in prematurely born women. J Natl Cancer Inst 2000;92:840-1.
46. Klopper A. Fetal monitoring. Biochemical methods. Baillieres Clin Obstet Gynaecol 1987;1:1-16.
47. Baer HJ, Colditz GA, Rosner BA, Michels KB, Rich-Edwards JW, Hunter DJ, Willett WC. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women. Breast Cancer Res 2005;7:R314-R325.
48. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
49. Troy LM, Michels KB, Hunter DJ, Spiegelman D, Manson JE, Colditz GA, Stampfer MJ, Willett WC. Self-reported birthweight and history of having been breastfed among younger women: an assessment of validity. Int J Epidemiol 1996;25:122-7.
50. Sanderson M, Williams MA, White E, Daling JR, Holt VL, Malone KE, Self SG, Moore DE. Validity and reliability of subject and mother reporting of perinatal factors. Am J Epidemiol 1998;147:136-40.
51. Tibblin G, Eriksson M, Cnattingius S, Ekbom A. High birthweight as a predictor of prostate cancer risk. Epidemiology 1995;6:423-4.
52. Akre O, Ekbom A, Hsieh CC, Trichopoulos D, Adami HO. Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst 1996;88:883-9.
53. Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development 1998;125:1921-30.
54. Russo J, Russo IH. Development of the human breast. Maturitas 2004;49:2-15.
55. Rudland PS, Barraclough R, Fernig DG, Smith JA. Growth and differentiation of the normal mammary gland and its tumors. Biochem Soc Symp 1996;63:1-20.
56. Russo J, Russo IH. Development of the human mammary gland. In: Neville MC, Daniel CW, eds. The mammary gland. New York: Plenum Press, 1987.67-93.
57. Laban C, Bustin SA, Jenkins PJ. The GH-IGF-I axis and breast cancer. Trends Endocrinol Metab 2003;14:28-34.
58. Anderson E, Clarke RB, Howell A. Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia 1998;3:23-35.
59. Kenney NJ, Dickson RB. Growth factor and sex steroid interactions in breast cancer. J Mammary Gland Biol Neoplasia 1996;1:189-98.
60. Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004;51:55-67.
61. Li Y, Rosen JM. Stem/Progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2005;10:17-24.
62. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif 2003;36(Suppl 1):59-72.
63. Beck F, Moffat DBM, Davies DP. Human embryology, 2nd ed. Oxford: Blackwell Scientific Publications, 1985.
64. Siiteri PK, MacDonald PC. Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab 1966;26:751-61.
65. Csapo AI, Pulkkinen MO, Wiest WG. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. Am J Obstet Gynecol 1973;115:759-65.
66. Tulchinsky D, Hobel CJ, Korenman SG. A radioligand assay for plasma unconjugated estriol in normal and abnormal pregnancies. Am J Obstet Gynecol 1971;111:311-8.
67. Lindberg BS, Johansson ED, Nilsson BA. Plasma levels of nonconjugated oestrone, oestradiol-17β and oestriol during uncomplicated pregnancy. Acta Obstet Gynecol Scand Suppl 1974;32:21-36.
68. Casey ML, MacDonald PC. Alterations in steroid production by the human placenta. In: Pasqualini JR, Scholler R, eds. Hormones and fetal pathophysiology. New York: Marcel Dekker, 1992. 251 p.
69. Troisi R, Potischman N, Roberts JM, Harger G, Markovic N, Cole B, Lykins D, Siiteri P, Hoover RN. Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiol Biomarkers Prev 2003;12:452-6.
70. MacMahon B, Cole P, Brown JB, Aoki K, Lin TM, Morgan RW, Woo NC. Urine oestrogen profiles of Asian and North American women. Int J Cancer 1974;14:161-7.
71. Lipworth L, Hsieh CC, Wide L, Ekbom A, Yu SZ, Yu GP, Xu B, Helerstein S, Carlstrom K, Trichopoulos D, Adami HO. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer 1999;79:7-12.
72. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35.
73. Service RE. New role for estrogen in cancer? Science 1998;279:1631-3.
74. Reik W, Walter J. Genomic imprinting: parental influence on the genome. Nat Rev Genet 2001;2:21-32.
75. Ali O, Cohen P. Insulin-like growth factors and their binding proteins in children born small for gestational age: implication for growth hormone therapy. Horm Res 2003;60(Suppl 3):115-23.
76. Hill DJ, Petrik J, Arany E. Growth factors and the regulation of fetal growth. Diabetes Care 1998;21:B60-B69.
77. Druckmann R, Rohr UD. IGF-1 in gynaecology and obstetrics: update 2002. Maturitas 2002;41(Suppl 1):S65-S83.
78. Westwood M, Gibson JM, Sooranna SR, Ward S, Neilson JP, Bajoria R. Genes or placenta as modulator of fetal growth: evidence from the insulin-like growth factor axis in twins with discordant growth. Mol Hum Reprod 2001;7:387-95.
79. Ostlund E, Tally M, Fried G. Transforming growth factor-β1 in fetal serum correlates with insulin-like growth factor-I and fetal growth. Obstet Gynecol 2002;100:567-73.
80. Spencer JA, Chang TC, Jones J, Robson SC, Preece MA. Third trimester fetal growth and umbilical venous blood concentrations of IGF-1, IGFBP-1, and growth hormone at term. Arch Dis Child Fetal Neonatal Ed 1995;73:F87-F90.
81. Fant M, Salafia C, Baxter RC, Schwander J, Vogel C, Pezzullo J, Moya F. Circulating levels of IGFs and IGF binding proteins in human cord serum: relationships to intrauterine growth. Regul Pept 1993;48:29-39.
82. Osorio M, Torres J, Moya F, Pezzullo J, Salafia C, Baxter R, Schwander J, Fant M. Insulin-like growth factors (IGFs) and IGF binding proteins-1, -2, and -3 in newborn serum: relationships to fetoplacental growth at term. Early Hum Dev 1996;46:15-26.
83. Wiznitzer A, Reece EA, Homko C, Furman B, Mazor M, Levy J. Insulin-like growth factors, their binding proteins, and fetal macrosomia in offspring of nondiabetic pregnant women. Am J Perinatol 1998;15:23-8.
84. Klauwer D, Blum WF, Hanitsch S, Rascher W, Lee PD, Kiess W. IGF-I, IGF-II, free IGF-I and IGFBP-1, -2 and -3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newborns. Acta Paediatr 1997;86:826-33.
85. Christou H, Connors JM, Ziotopoulou M, Hatzidakis V, Papathanassoglou E, Ringer SA, Mantzoros CS. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab 2001;86:935-8.
86. Boyne MS, Thame M, Bennett FI, Osmond C, Miell JP, Forrester TE. The relationship among circulating insulin-like growth factor (IGF)-I, IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study. J Clin Endocrinol Metab 2003;88:1687-91.
87. Coutant R, Boux de Casson F, Douay O, Mathieu E, Rouleau S, Beringue F, Gillard P, Limai JM, Descamps P. Relationships between placental GH concentration and maternal smoking, newborn gender, and maternal leptin: possible implications for birth weight. J Clin Endocrinol Metab 2001;86:4854-9.
88. Zhou J, Shi Y, Dong M. The effect of insulin-like growth factor I and insulin on intrauterine fetal growth retardation. Zhonghua Fu Chan Ke Za Zhi 1999;34:222-4.
89. Ferguson S, Rogers M, Chung T, Chard T, Wang HS, Owens P, Moyse K. IGF-I and IGFBP-I in pregnancy are related to glucose metabolism and fetal growth. Proceedings of the 3rd International Symposium on Insulin-Like Growth Factors. Growth Regul 1994;4:112.
90. Hall K, Hansson U, Lundin G, Luthman M, Persson B, Povoa G, Stangenberg M, Ofverholm U. Serum levels of somatomedins and somatomedin-binding protein in pregnant women with type I or gestational diabetes and their infants. J Clin Endocrinol Metab 1986;63:1300-6.
91. Caufriez A, Frankenne F, Hennen G, Copinschi G. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol 1993;265:E572-E577.
92. Harding JE, Evans PC, Gluckman PD. Maternal growth hormone treatment increases placental diffusion capacity but not fetal or placental growth in sheep. Endocrinology 1997;138:5352-8.
93. McIntyre HD, Serek R, Crane DI, Veveris-Lowe T, Parry A, Johnson S, Leung KC, Ho KK, Bougoussa M, Hennen G, Igout A, Chan FY, Cowley D, Cotterill A, Barnard R. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab 2000;85:1143-50.
94. Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996;76:1005-26.
95. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002;417:945-8.
96. Ferguson-Smith AC, Surani MA. Imprinting and the epigenetic asymmetry between parental genomes. Science 2001;293:1086-9.
97. Tilghman SM. The sins of the fathers and mothers: genomic imprinting in mammalian development. Cell 1999;96:185-93.
98. Reik W, Davies K, Dean W, Kelsey G, Constancia M. Imprinted genes and the coordination of fetal and postnatal growth in mammals. Novartis Found Symp 2001;237:19-31; discussion 31-42.
99. McCann AH, Miller N, O'Meara A, Pedersen I, Keogh K, Gorey T, Dervan PA. Biallelic expression of the IGF2 gene in human breast disease. Hum Mol Genet 1996;5:1123-7.
100. Barlow DP. Gametic imprinting in mammals. Science 1995;270:1610-3.
101. Ohlsson R, Larsson E, Nilsson O, Wahlstrom T, Sundstrom P. Blastocyst implantation precedes induction of insulin-like growth factor II gene expression in human trophoblasts. Development 1989;106:555-9.
102. Burns JL, Hassan AB. Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation. Development 2001;128:3819-30.
103. Wang ZQ, Fung MR, Barlow DP, Wagner EF. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 1994;372:464-7.
104. Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 1994;8:2953-63.
105. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 1995;375:34-9.
106. Sun FL, Dean WL, Kelsey G, Allen ND, Reik W. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 1997;389:809-15.
107. Morgan HD, Santos F, Green K, Dean W, Reik W. Epigenetic reprogramming in mammals. Hum Mol Genet 2005;14 Spec No 1:R47-R58.
108. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001;293:1089-93.
109. Rideout WM, III, Eggan K, Jaenisch R. Nuclear cloning and epigenetic reprogramming of the genome. Science 2001;293:1093-8.
110. Razin A, Riggs AD. DNA methylation and gene function. Science 1980;210:604-10.
111. Tremblay KD, Duran KL, Bartolomei MS. A 5′2-kilobase-pair region of imprinted mouse H19 gene exhibits exclusive paternal methylation throughout development. Mol Cell Biol 1997;17:4322-9.
112. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33 Suppl:245-54.
113. Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998;12:949-57.
114. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23:5293-300.
115. Feinberg AP. Genomic imprinting and gene activation in cancer. Nat Genet 1993;4:110-3.
116. Feinberg AP. The epigenetics of cancer etiology. Semin Cancer Biol 2004;14:427-432.
117. Wu HK, Squire JA, Catzavelos CG, Weksberg R. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas. Biochem Biophys Res Commun 1997;235:123-9.
118. van Roozendaal CEP, Gillis AJM, Klijn JGM, van Ooijen B, Claassen CJC, Eggermont AMM, Henzen-Logmans SC, Oosterhuis JW, Foekens JA, Looijenga LHJ. Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures. FEBS Lett 1998;437:107-11.
119. Christofori G, Naik P, Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 1994;369:414-8.
120. Brice AL, Cheetham JE, Bolton VN, Hill NC, Schofield PN. Temporal changes in the expression of the insulin-like growth factor II gene associated with tissue maturation in the human fetus. Development 1989;106:543-4.
121. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 1988;48:6691-6.
122. Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 1991;51:4978-85.
123. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT, Cullen KJ. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res 1995;55:2448-54.
124. Giani C, Cullen KJ, Campani D, Rasmussen A. IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ hybridization and immunohistochemistry study. Breast Cancer Res Treat 1996;41:43-50.
125. Paik S. Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res Treat 1992;22:31-8.
126. Ottaviano YL, Issa JP, Pari FF, Smith HS, Baylin SB, Davidson NE. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 1994;54:2552-5.
127. Ferguson AT, Lapidus RG, Baylin SB, Davidson NE. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res 1995;55:2279-83.
128. Lapidus RG, Nass SJ, Butash KA, Parl FF, Weitzman SA, Graff JG, Herman JG, Davidson NE. Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res 1998;58:2515-9.
129. Iwase H, Omoto Y, Iwata H, Toyama T, Hara Y, Ando Y, Ito Y, Fujii Y, Kobayashi S. DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers. Br J Cancer 1999;80:1982-6.
130. Meeuuwisse G, Olausson PO. Increased birth weights in the Nordic countries. A growing proportion of neonates weigh more than four kilos. Lakartidningen 1998;95:5488-92.
131. Lagiou P, Hsieh CC, Trichopoulos D, Xu B, Wuu J, Mucci L, Tamimi R, Adami HO, Cnattingius S. Birthweight differences between USA and China and their relevance to breast cancer aetiology. Int J Epidemiol 2003;32:193-8.
132. Wang X, Guyer B, Paige DM. Differences in gestational age-specific birthweight among Chinese, Japanese and white Americans. Int J Epidemiol 1994;23:119-28.
133. Wen SW, Kramer MS, Usher RH. Comparison of birth weight distributions between Chinese and Caucasian infants. Am J Epidemiol 1995;141:1177-87.